El violeta de genciana como fármaco tópico en las dermatitis de origen flebostático
Leído
43164
Vecesse ha leído el artículo
40517
Total PDF
2647
Total HTML
Información del artículo
ISSN: 00033170Idioma original: Español
Datos actualizados diariamente
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 12 | 10 | 34 | 44 |
| 2025 11 | 29 | 270 | 299 |
| 2025 10 | 29 | 310 | 339 |
| 2025 9 | 34 | 287 | 321 |
| 2025 8 | 30 | 308 | 338 |
| 2025 7 | 27 | 405 | 432 |
| 2025 6 | 23 | 543 | 566 |
| 2025 5 | 15 | 596 | 611 |
| 2025 4 | 25 | 561 | 586 |
| 2025 3 | 32 | 773 | 805 |
| 2025 2 | 29 | 754 | 783 |
| 2025 1 | 20 | 989 | 1009 |
| 2024 12 | 11 | 866 | 877 |
| 2024 11 | 24 | 933 | 957 |
| 2024 10 | 25 | 1596 | 1621 |
| 2024 9 | 42 | 1610 | 1652 |
| 2024 8 | 26 | 1687 | 1713 |
| 2024 7 | 29 | 1744 | 1773 |
| 2024 6 | 25 | 1539 | 1564 |
| 2024 5 | 27 | 1821 | 1848 |
| 2024 4 | 28 | 1612 | 1640 |
| 2024 3 | 29 | 1419 | 1448 |
| 2024 2 | 31 | 1551 | 1582 |
| 2024 1 | 28 | 1407 | 1435 |
| 2023 12 | 13 | 1182 | 1195 |
| 2023 11 | 18 | 1399 | 1417 |
| 2023 10 | 32 | 1579 | 1611 |
| 2023 9 | 17 | 1307 | 1324 |
| 2023 8 | 18 | 1355 | 1373 |
| 2023 7 | 32 | 1314 | 1346 |
| 2023 6 | 78 | 1017 | 1095 |
| 2023 5 | 74 | 1002 | 1076 |
| 2023 4 | 42 | 603 | 645 |
| 2023 3 | 15 | 475 | 490 |
| 2023 2 | 17 | 458 | 475 |
| 2022 1 | 16 | 459 | 475 |
| 2022 12 | 20 | 428 | 448 |
| 2022 11 | 22 | 413 | 435 |
| 2022 10 | 20 | 390 | 410 |
| 2022 9 | 16 | 362 | 378 |
| 2022 8 | 23 | 257 | 280 |
| 2022 7 | 19 | 188 | 207 |
| 2022 6 | 20 | 75 | 95 |
| 2022 5 | 36 | 94 | 130 |
| 2022 4 | 32 | 72 | 104 |
| 2022 3 | 33 | 99 | 132 |
| 2022 2 | 41 | 68 | 109 |
| 2021 1 | 44 | 113 | 157 |
| 2021 12 | 29 | 70 | 99 |
| 2021 11 | 35 | 79 | 114 |
| 2021 10 | 48 | 81 | 129 |
| 2021 9 | 37 | 79 | 116 |
| 2021 8 | 25 | 69 | 94 |
| 2021 7 | 21 | 66 | 87 |
| 2021 6 | 21 | 86 | 107 |
| 2021 5 | 29 | 110 | 139 |
| 2021 4 | 71 | 458 | 529 |
| 2021 3 | 52 | 129 | 181 |
| 2021 2 | 30 | 86 | 116 |
| 2020 1 | 55 | 108 | 163 |
| 2020 12 | 46 | 90 | 136 |
| 2020 11 | 37 | 67 | 104 |
| 2020 10 | 20 | 45 | 65 |
| 2020 9 | 21 | 60 | 81 |
| 2020 8 | 38 | 49 | 87 |
| 2020 7 | 39 | 54 | 93 |
| 2020 6 | 38 | 44 | 82 |
| 2020 5 | 38 | 35 | 73 |
| 2020 4 | 19 | 15 | 34 |
| 2020 3 | 10 | 13 | 23 |
| 2020 2 | 0 | 7 | 7 |
| 2020 1 | 0 | 9 | 9 |
| 2019 12 | 0 | 9 | 9 |
| 2019 11 | 0 | 3 | 3 |
| 2019 10 | 0 | 6 | 6 |
| 2019 9 | 0 | 2 | 2 |
| 2019 8 | 0 | 1 | 1 |
| 2019 7 | 0 | 9 | 9 |
| 2019 6 | 0 | 24 | 24 |
| 2019 5 | 0 | 37 | 37 |
| 2018 3 | 1 | 0 | 1 |
| 2018 2 | 15 | 3 | 18 |
| 2018 1 | 15 | 0 | 15 |
| 2017 12 | 11 | 3 | 14 |
| 2017 11 | 21 | 1 | 22 |
| 2017 10 | 25 | 3 | 28 |
| 2017 9 | 22 | 1 | 23 |
| 2017 8 | 24 | 0 | 24 |
| 2017 7 | 28 | 1 | 29 |
| 2017 6 | 26 | 4 | 30 |
| 2017 5 | 32 | 0 | 32 |
| 2017 4 | 88 | 0 | 88 |
| 2017 3 | 93 | 4 | 97 |
| 2017 2 | 25 | 3 | 28 |
| 2016 1 | 14 | 1 | 15 |
| 2016 12 | 22 | 4 | 26 |
| 2016 11 | 23 | 6 | 29 |
| 2016 10 | 19 | 8 | 27 |
| 2016 9 | 15 | 2 | 17 |
| 2016 8 | 16 | 6 | 22 |
| 2016 7 | 5 | 4 | 9 |
| 2016 6 | 5 | 9 | 14 |
| 2016 5 | 4 | 10 | 14 |
| 2016 4 | 4 | 8 | 12 |
| 2016 3 | 4 | 9 | 13 |
| 2016 2 | 3 | 12 | 15 |
| 2015 1 | 0 | 8 | 8 |
| 2015 12 | 2 | 7 | 9 |
| 2015 11 | 0 | 5 | 5 |
| 2015 10 | 0 | 4 | 4 |
| 2015 9 | 0 | 3 | 3 |
| 2015 8 | 0 | 1 | 1 |
| 2015 7 | 0 | 4 | 4 |
| 2015 6 | 0 | 1 | 1 |
| 2015 5 | 0 | 4 | 4 |
| 2015 4 | 0 | 5 | 5 |
| 2015 3 | 0 | 3 | 3 |
| 2015 1 | 0 | 6 | 6 |
| 2014 12 | 0 | 4 | 4 |
| 2014 11 | 0 | 3 | 3 |
| 2014 10 | 0 | 3 | 3 |
| 2014 9 | 0 | 1 | 1 |
| 2014 8 | 0 | 4 | 4 |
| 2014 7 | 0 | 3 | 3 |
| 2014 6 | 0 | 3 | 3 |
| 2014 5 | 0 | 3 | 3 |
| 2014 2 | 0 | 1 | 1 |
| 2014 1 | 0 | 3 | 3 |
| 2013 12 | 0 | 2 | 2 |
| 2013 10 | 0 | 3 | 3 |
| 2013 9 | 0 | 2 | 2 |
| 2013 8 | 0 | 1 | 1 |
| 2013 7 | 0 | 3 | 3 |
| 2013 6 | 0 | 1 | 1 |
Mostrar todo
